Citations (119)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Yahui Grace Chiu & Christopher T. Ritchlin. (2017) Denosumab: targeting the RANKL pathway to treat rheumatoid arthritis. Expert Opinion on Biological Therapy 17:1, pages 119-128.
Read now
Read now
Mette Bjerre, Jørgen Hilden, Jens Kastrup, Maria Skoog, Jørgen F. Hansen, Hans J. Kolmos, Gorm B. Jensen, Erik Kjøller, Per Winkel, Allan Flyvbjerg & Christian Gluud. (2014) Osteoprotegerin independently predicts mortality in patients with stable coronary artery disease: The CLARICOR trial. Scandinavian Journal of Clinical and Laboratory Investigation 74:8, pages 657-664.
Read now
Read now
A Fisher, W Srikusalanukul, M Davis & P Smith. (2013) Cardiovascular diseases in older patients with osteoporotic hip fracture: prevalence, disturbances in mineral and bone metabolism, and bidirectional links. Clinical Interventions in Aging 8, pages 239-256.
Read now
Read now
Tae-Jin Song, Jinkwon Kim, Seung-Hee Yang, Ji Hye Park, Hye Sun Lee, Chung Mo Nam, Ok-Hee Lee, Young Dae Kim, Hyo Suk Nam & Ji Hoe Heo. (2012) Association of plasma osteoprotegerin levels with stroke severity and functional outcome in acute ischaemic stroke patients. Biomarkers 17:8, pages 738-744.
Read now
Read now
Articles from other publishers (115)
Urban Alehagen, Jan Alexander, Jan O. Aaseth, Anders Larsson, Erland Svensson & Trine B. Opstad. (2023) Effects of an Intervention with Selenium and Coenzyme Q10 on Five Selected Age-Related Biomarkers in Elderly Swedes Low in Selenium: Results That Point to an Anti-Ageing Effect—A Sub-Analysis of a Previous Prospective Double-Blind Placebo-Controlled Randomised Clinical Trial. Cells 12:13, pages 1773.
Crossref
Crossref
Annop Kittithaworn, David Toro-Tobon & Jad G Sfeir. (2023) Cardiovascular benefits and risks associated with calcium, vitamin D, and antiresorptive therapy in the management of skeletal fragility. Women's Health 19, pages 174550572311700.
Crossref
Crossref
Alejandro Rodríguez Ruiz, Marcella van Hoolwerff, Sara Sprangers, Eka Suchiman, Ton Schoenmaker, Petra Dibbets-Schneider, Johan L Bloem, Rob G H H Nelissen, Christian Freund, Christine Mummery, Vincent Everts, Teun J de Vries, Yolande F M Ramos & Ingrid Meulenbelt. (2023) Mutation in the CCAL1 locus accounts for bidirectional process of human subchondral bone turnover and cartilage mineralization. Rheumatology 62:1, pages 360-372.
Crossref
Crossref
Yan Zhang, Jingqi Liang, Peilong Liu, Qiong Wang, Liang Liu & Hongmou Zhao. (2022) The RANK/RANKL/OPG system and tumor bone metastasis: Potential mechanisms and therapeutic strategies. Frontiers in Endocrinology 13.
Crossref
Crossref
Hyung Jun Kim, Moo-Seok Park, Ahran Joo, Seungji Kang, Seuhyun Eum, Yoonkyung Chang & Tae-Jin Song. (2022) Plasma osteoprotegerin level is associated with hemorrhagic transformation in stroke patients who underwent endovascular thrombectomy. Clinical Neurology and Neurosurgery 219, pages 107305.
Crossref
Crossref
Moo-Seok Park, Jin-Hee Park, Ahran Joo, Yoonkyung Chang & Tae-Jin Song. (2022) The association of plasma osteoprotegerin levels and functional outcomes post endovascular thrombectomy in acute ischemic stroke patients: a retrospective observational study. PeerJ 10, pages e13327.
Crossref
Crossref
Jie Chen, Tong Wang, Hongbing Xu, Yutong Zhu, Yipeng Du, Beibei Liu, Qian Zhao, Yi Zhang, Lingyan Liu, Ningman Yuan, Jiakun Fang, Yunfei Xie, Shuo Liu, Rongshan Wu, Danqing Shao, Xiaoming Song, Bei He, Bert Brunekreef & Wei Huang. (2022) An extended analysis of cardiovascular benefits of indoor air filtration intervention among elderly: a randomized crossover trial (Beijing indoor air purifier study, BIAPSY). Global Health Journal 6:1, pages 30-34.
Crossref
Crossref
Mutlu Gunes, Sule Temizkan, Tugce Apaydin, Can Ilgin, Goncagul Haklar & Dilek Gogas Yavuz. (2021) Serum osteoprotegerin levels, endothelial function and carotid intima-media thickness in type 2 diabetic patients. Journal of Diabetes and its Complications 35:12, pages 108073.
Crossref
Crossref
Moo-Seok Park, Yoonkyung Chang, Kwang-Hyun Kim, Jin Hee Park & Tae-Jin Song. (2021) Plasma osteoprotegerin levels are associated with the presence and burden of cerebral small vessel disease in patients with acute ischemic stroke. Clinical Neurology and Neurosurgery 210, pages 107010.
Crossref
Crossref
Preethi Cherian, Irina Al-Khairi, Mohammad Jamal, Suleiman Al-Sabah, Hamad Ali, Carol Dsouza, Eman Alshawaf, Waleed Al-Ali, Ghanim Al-Khaledi, Fahd Al-Mulla, Mohamed Abu-Farha & Jehad Abubaker. (2021) Association Between Factors Involved in Bone Remodeling (Osteoactivin and OPG) With Plasma Levels of Irisin and Meteorin-Like Protein in People With T2D and Obesity. Frontiers in Endocrinology 12.
Crossref
Crossref
Anita Pusztai, Attila Hamar, Monika Czókolyová, Katalin Gulyás, Ágnes Horváth, Edit Végh, Zsófia Pethő, Szilvia Szamosi, Emese Balogh, Nóra Bodnár, Levente Bodoki, Ágnes Szentpétery, Harjit Pal Bhattoa, György Kerekes, Balázs Juhász, Éva Szekanecz, Katalin Hodosi, Andrea Domján, Sándor Szántó, Hennie G. Raterman, Willem F. Lems, Zoltán Szekanecz & Gabriella Szűcs. (2021) Associations of vascular and bone status in arthritis patients. Scientific Reports 11:1.
Crossref
Crossref
Yves Cottin, Rany Issa, Mourad Benalia, Basile Mouhat, Alexandre Meloux, Laura Tribouillard, Florence Bichat, Luc Rochette, Catherine Vergely & Marianne Zeller. (2021) Association between Serum Osteoprotegerin Levels and Severity of Coronary Artery Disease in Patients with Acute Myocardial Infarction. Journal of Clinical Medicine 10:19, pages 4326.
Crossref
Crossref
Mirthe Dekker, Farahnaz Waissi, Max J. M. Silvis, Joelle V. Bennekom, Arjan H. Schoneveld, Robbert J. de Winter, Ivana Isgum, Nikolas Lessmann, Birgitta K. Velthuis, Gerard Pasterkamp, Arend Mosterd, Leo Timmers & Dominique P. V. de Kleijn. (2021) High levels of osteoprotegerin are associated with coronary artery calcification in patients suspected of a chronic coronary syndrome. Scientific Reports 11:1.
Crossref
Crossref
Ruoyu Zhou, Qiaoyue Guo, Ye Xiao, Qi Guo, Yan Huang, Changjun Li & Xianghang Luo. (2021) Endocrine role of bone in the regulation of energy metabolism. Bone Research 9:1.
Crossref
Crossref
Jin Sug Kim & Hyeon Seok Hwang. (2021) Vascular Calcification in Chronic Kidney Disease: Distinct Features of Pathogenesis and Clinical Implication. Korean Circulation Journal 51:12, pages 961.
Crossref
Crossref
Reiko Hanada. (2020) The role of the RANKL/RANK/OPG system in the central nervous systems (CNS). Journal of Bone and Mineral Metabolism 39:1, pages 64-70.
Crossref
Crossref
Jaehoon Chung, Hack-Lyoung Kim, Jung Pyo Lee, Woo-Hyun Lim, Jae-Bin Seo, Sang-Hyun Kim, Joo-Hee Zo & Myung-A Kim. (2020) Association of the Serum Osteoprotegerin Level With Target Organ Damage in Patients at High Risk of Coronary Artery Disease. Circulation Journal 85:1, pages 69-76.
Crossref
Crossref
Lisanne TapFrances A. KirkhamFrancesco Mattace-RasoLaure JolyChakravarthi RajkumarAthanase Benetos. (2020) Unraveling the Links Underlying Arterial Stiffness, Bone Demineralization, and Muscle Loss. Hypertension 76:3, pages 629-639.
Crossref
Crossref
Melody P. Chung, Carrie Richardson, David Kirakossian, Amir B. Orandi, Lesley A. Saketkoo, Lisa G. Rider, Adam Schiffenbauer, Carlos A. von Mühlen & Lorinda Chung. (2020) Calcinosis Biomarkers in Adult and Juvenile Dermatomyositis. Autoimmunity Reviews 19:6, pages 102533.
Crossref
Crossref
Mette Bjerre, Jørgen Hilden, Per Winkel, Gorm Boje Jensen, Erik Kjøller, Ahmad Sajadieh, Jens Kastrup, Hans Jørn Kolmos, Anders Larsson, Johan Ärnlöv, Janus Christian Jakobsen & Christian Gluud. (2020) Serum osteoprotegerin as a long-term predictor for patients with stable coronary artery disease and its association with diabetes and statin treatment: A CLARICOR trial 10-year follow-up substudy. Atherosclerosis 301, pages 8-14.
Crossref
Crossref
Fang Lv, Xiaoling Cai, Wenjia Yang, Leili Gao, Ling Chen, Jing Wu & Linong Ji. (2020) Denosumab or romosozumab therapy and risk of cardiovascular events in patients with primary osteoporosis: Systematic review and meta- analysis. Bone 130, pages 115121.
Crossref
Crossref
Carolina Di Somma, Volha V. Zhukouskaya, Elisabetta Scarano, Rosario Pivonello & Annamaria Colao. 2020. Male Osteoporosis. Male Osteoporosis
153
161
.
Maximillian A. Rogers & Elena Aikawa. 2020. Cardiovascular Calcification and Bone Mineralization. Cardiovascular Calcification and Bone Mineralization
73
95
.
Zoltán Szekanecz, Hennie G. Raterman, Zsófia Pethő & Willem F. Lems. (2019) Common mechanisms and holistic care in atherosclerosis and osteoporosis. Arthritis Research & Therapy 21:1.
Crossref
Crossref
Emese Balogh, Anita Pusztai, Attila Hamar, Edit Végh, Szilvia Szamosi, György Kerekes, Jennifer McCormick, Monika Biniecka, Sándor Szántó, Gabriella Szűcs, Zoltán Nagy, Ursula Fearon, Douglas J. Veale & Zoltán Szekanecz. (2019) Autoimmune and angiogenic biomarkers in autoimmune atherosclerosis. Clinical Immunology 199, pages 47-51.
Crossref
Crossref
Shuai He, Fulai Nian, Wen Chen, Li Yin, Merveesh L. Auchoybur, Zhonghao Tao, Shaowen Tang & Xin Chen. (2019) I-κB kinase-ε knockout protects against angiotensin II induced aortic valve thickening in apolipoprotein E deficient mice. Biomedicine & Pharmacotherapy 109, pages 1287-1295.
Crossref
Crossref
A. T. Teplyakov, E. N. Berezikova, S. N. Shilov, A. A. Popova, I. V. Yakovleva, A. V. Molokov, E. V. Grakova, K. V. Kopeva, A. V. Svarovskaya, O. V. Garmaeva, Yu. Yu. Torim, E. I. Stepachev & V. V. Kalyuzhin. (2018) Osteoprotegerin is a new independent predictor of the progression of cardiovascular pathology: chronic heart failure associated with type 2 diabetes and osteoporosis. Bulletin of Siberian Medicine 17:4, pages 141-151.
Crossref
Crossref
Xiaochao Zhang, Renhua Yang, Jiang Long, Bo He, Yue Zhang, Ting Fu, Zhiqiang Shen & Peng Chen. (2018) A novel effect of geraniin on OPG/RANKL signaling in osteoblasts. Brazilian Journal of Pharmaceutical Sciences 54:3.
Crossref
Crossref
Thomas Schachtner, Natalie M Otto & Petra Reinke. (2018) Cyclosporine use and male gender are independent determinants of avascular necrosis after kidney transplantation: a cohort study. Nephrology Dialysis Transplantation 33:11, pages 2060-2066.
Crossref
Crossref
James C. Connors, Mark A. Hardy, Lauren L. Kishman, Georgeanne G. Botek, Craig J. Verdin, Nilin M. Rao & J. Derek Kingsley. (2018) Charcot Pathogenesis: A Study of In Vivo Gene Expression. The Journal of Foot and Ankle Surgery 57:6, pages 1067-1072.
Crossref
Crossref
Lena Tschiderer, Gerhard Klingenschmid, Rajini Nagrani, Johann Willeit, Jari A. Laukkanen, Georg Schett, Stefan Kiechl & Peter Willeit. (2018) Osteoprotegerin and Cardiovascular Events in High‐Risk Populations: Meta‐Analysis of 19 Prospective Studies Involving 27 450 Participants. Journal of the American Heart Association 7:16.
Crossref
Crossref
José Alberto García-Lozano, Jorge Ocampo-Candiani, Sylvia Aide Martínez-Cabriales & Verónica Garza-Rodríguez. (2018) An Update on Calciphylaxis. American Journal of Clinical Dermatology 19:4, pages 599-608.
Crossref
Crossref
Xin Xiong, Duraid Hamied Naji, Binbin Wang, Yuanyuan Zhao, Junhan Wang, Dan Wang, Yuting Zhang, Sisi Li, Shanshan Chen, Yufeng Huang, Qin Yang, Xiaojing Wang, Dan Yin, Xin Tu, Qiuyun Chen, Xu Ma, Chengqi Xu & Qing K. Wang. (2018) Significant Association between OPG/TNFRSF11B Variant and Common Complex Ischemic Stroke. Journal of Stroke and Cerebrovascular Diseases 27:6, pages 1683-1691.
Crossref
Crossref
Katarína Demková, Miriam Kozárová, Zuzana Malachovská, Martin Javorský & Ivan Tkáč. (2018) Osteoprotegerin concentration is associated with the presence and severity of peripheral arterial disease in type 2 diabetes mellitus. Vasa 47:2, pages 131-135.
Crossref
Crossref
Jian Sun, Xiaoyue Zhang, Renmei Li, Zhengxi Chen, Yuanliang Huang & Zhenqi Chen. (2018) Biological Effects of Orthodontic Tooth Movement Into the Grafted Alveolar Cleft. Journal of Oral and Maxillofacial Surgery 76:3, pages 605-615.
Crossref
Crossref
Ana Paula Silva, Anabela Malho Guedes & Pedro Leão Neves. 2018. Chronic Kidney Disease - from Pathophysiology to Clinical Improvements. Chronic Kidney Disease - from Pathophysiology to Clinical Improvements.
Luc Rochette, Alexandre Meloux, Eve Rigal, Marianne Zeller, Yves Cottin & Catherine Vergely. (2018) The role of osteoprotegerin in the crosstalk between vessels and bone: Its potential utility as a marker of cardiometabolic diseases. Pharmacology & Therapeutics 182, pages 115-132.
Crossref
Crossref
Sílvia Collado, Elisabeth Coll, Carlos Nicolau, Manel Azqueta, Mercedes Pons, Josep M Cruzado, Bernat de la Torre, Ramón Deulofeu, Sergi Mojal, Julio Pascual & Aleix Cases. (2017) Serum osteoprotegerin in prevalent hemodialysis patients: associations with mortality, atherosclerosis and cardiac function. BMC Nephrology 18:1.
Crossref
Crossref
Lena Tschiderer, Johann Willeit, Georg Schett, Stefan Kiechl & Peter Willeit. (2017) Osteoprotegerin concentration and risk of cardiovascular outcomes in nine general population studies: Literature-based meta-analysis involving 26,442 participants. PLOS ONE 12:8, pages e0183910.
Crossref
Crossref
Meenal Mavinkurve & Clodagh S. O’Gorman. (2017) Can Brain Natriuretic Peptides and Osteoprotegerin Serve As Biochemical Markers for the Detection of Aortic Pathology in Children and Adolescents with Turner Syndrome?. Frontiers in Endocrinology 8.
Crossref
Crossref
Dionisios Chrysis, Alexandra Efthymiadou, Alexandra Mermigka, Dimitra Kritikou & Bessie E Spiliotis. (2017) Osteoprotegerin, RANKL, ADMA, and Fetuin-A serum levels in children with type I diabetes mellitus. Pediatric Diabetes 18:4, pages 277-282.
Crossref
Crossref
Tarek Z. El Baz, Osama A. Khamis, Amal El-Shehaby, Hussein Chahine, Ahmad Alaa Al-Din Ahmed & Mostafa A. Alsawasany. (2017) Relationship between serum osteoprotegerin and vascular calcifications in hemodialysis patients. The Egyptian Heart Journal 69:2, pages 149-155.
Crossref
Crossref
Mable Misha Singh, Ravindra Kumar, Satyendra Tewari & Sarita Agarwal. (2017) Investigation of OPG/RANK/RANKL Genes as a Genetic Marker for Cardiac abnormalities in Thalassemia Major Patients. Annals of Human Genetics 81:3, pages 117-124.
Crossref
Crossref
Bożena Bruhn-Olszewska, Anna Korzon-Burakowska, Grzegorz Węgrzyn & Joanna Jakóbkiewicz-Banecka. (2017) Prevalence of polymorphisms in OPG, RANKL and RANK as potential markers for Charcot arthropathy development. Scientific Reports 7:1.
Crossref
Crossref
Jolanta M. Siller-Matula, Irene M. Lang, Christian Schoergenhofer, Mark Roest & Bernd Jilma. (2017) Interdependence between osteoprotegerin and active von Willebrand factor in long-term cardiovascular mortality prediction in patients undergoing percutaneous coronary intervention. Thrombosis and Haemostasis 117:09, pages 1730-1738.
Crossref
Crossref
Gernot Pichler, Maria C. Haller, Alexander Kainz, Myles Wolf, Josep Redon & Rainer Oberbauer. (2016) Prognostic value of bone- and vascular-derived molecular biomarkers in hemodialysis and renal transplant patients: a systematic review and meta-analysis. Nephrology Dialysis Transplantation, pages gfw387.
Crossref
Crossref
A. Dolzhenko, T. Richter & S. Sagalovsky. (2016) VASCULAR CALCIFICATION, ATHEROSCLEROSIS AND BONE LOSS (OSTEOPOROSIS): NEW PATHOPHYSIOLOGICAL MECHANISMS AND FUTURE PERSPECTIVES FOR PHARMACOLOGICAL THERAPY. Almanac of Clinical Medicine 44:4, pages 513-534.
Crossref
Crossref
Münevver Serdaroğlu Beyazal, Turan Erdoğan, Aysegül Kücükali Türkyılmaz, Gül Devrimsel, Medine Cumhur Cüre, Mehmet Beyazal & Ismail Sahin. (2016) Relationship of serum osteoprotegerin with arterial stiffness, preclinical atherosclerosis, and disease activity in patients with ankylosing spondylitis. Clinical Rheumatology 35:9, pages 2235-2241.
Crossref
Crossref
Alexander Berezin. (2016) Is rationale to decrease serum osteoprotegerin and fetuin-A in type 2 diabetes mellitus patients?. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 10:3, pages 169-170.
Crossref
Crossref
N. Schweighofer, A. Aigelsreiter, O. Trummer, M. Graf-Rechberger, N. Hacker, D. Kniepeiss, D. Wagner, P. Stiegler, C. Trummer, T. Pieber, B. Obermayer-Pietsch & H. Müller. (2016) Direct comparison of regulators of calcification between bone and vessels in humans. Bone 88, pages 31-38.
Crossref
Crossref
Jingchao Lu, Fan Liu, Demin Liu, Hong Du, Jie Hao, Xiuchun Yang & Wei Cui. (2016) Amlodipine and atorvastatin improved hypertensive cardiac hypertrophy through regulation of receptor activator of nuclear factor kappa B ligand/receptor activator of nuclear factor kappa B/osteoprotegerin system in spontaneous hypertension rats. Experimental Biology and Medicine 241:11, pages 1237-1249.
Crossref
Crossref
Alessandra D’Abramo, Maria Antonella Zingaropoli, Alessandra Oliva, Claudia D’Agostino, Samir Al Moghazi, Giulia De Luca, Marco Iannetta, Gabriella d’Ettorre, Maria Rosa Ciardi, Claudio Maria Mastroianni & Vincenzo Vullo. (2016) Higher Levels of Osteoprotegerin and Immune Activation/Immunosenescence Markers Are Correlated with Concomitant Bone and Endovascular Damage in HIV-Suppressed Patients. PLOS ONE 11:2, pages e0149601.
Crossref
Crossref
Stella Bernardi, Fleur Bossi, Barbara Toffoli & Bruno Fabris. (2016) Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease. BioMed Research International 2016, pages 1-12.
Crossref
Crossref
S. C. van Dijk, R. T. de Jongh, A. W. Enneman, A. C. Ham, K. M. A. Swart, J. P. van Wijngaarden, N. L. van der Zwaluw, E. M. Brouwer-Brolsma, N. M. van Schoor, R. A. M. Dhonukshe-Rutten, P. Lips, C. P. G. M. de Groot, Y. M. Smulders, H. J. Blom, E. J. Feskens, J. M. Geleijnse, A. H. van den Meiracker, F. U. S. Mattace Raso, A. G. Uitterlinden, M. C. Zillikens & N. van der Velde. (2015) Arterial stiffness is not associated with bone parameters in an elderly hyperhomocysteinemic population. Journal of Bone and Mineral Metabolism 34:1, pages 99-108.
Crossref
Crossref
Clarisse Noël Ayina Ayina, Eugene Sobngwi, Mickael Essouma, Jean Jacques N. Noubiap, Philippe Boudou, Laurent Serge Etoundi Ngoa & Jean François Gautier. (2015) Osteoprotegerin in relation to insulin resistance and blood lipids in sub-Saharan African women with and without abdominal obesity. Diabetology & Metabolic Syndrome 7:1.
Crossref
Crossref
Yixin Niu, Zhen Yang, Xiaoyong Li, Weiwei Zhang, Shuai Lu, Hongmei Zhang, Xueru Chen, Lingfei Zhu, Yin Xing, Guang Ning, Li Qin & Qing Su. (2015) Association of osteoprotegerin with impaired glucose regulation and microalbuminuria: the REACTION study. BMC Endocrine Disorders 15:1.
Crossref
Crossref
Yixin Niu, Weiwei Zhang, Zhen Yang, Xiaoyong Li, Jie Wen, Suijun Wang, Hongmei Zhang, Xuanchun Wang, Houguang Zhou, Wenjun Fang, Li Qin & Qing Su. (2015) Association of plasma osteoprotegerin levels with the severity of lower extremity arterial disease in patients with type 2 diabetes. BMC Cardiovascular Disorders 15:1.
Crossref
Crossref
Kerunne S. Ketlogetswe, Rebeccah McKibben, Lisa P. Jacobson, Xuihong Li, Adrian S. Dobs, Matthew Budoff, Mallory D. Witt, Frank J. Palella, Lawrence Kingsley, Joseph B. Margolick, Wendy S. Post & Todd T. Brown. (2015) Osteoprotegerin, but Not Receptor Activator for Nuclear Factor-κB Ligand, is Associated With Subclinical Coronary Atherosclerosis in HIV-Infected Men. JAIDS Journal of Acquired Immune Deficiency Syndromes 70:4, pages 362-369.
Crossref
Crossref
Fernando Friões, Olga Laszczynska, Pedro-Bernardo Almeida, Nuno Silva, João-Tiago Guimarães, Torbjørn Omland, Ana Azevedo & Paulo Bettencourt. (2015) Prognostic Value of Osteoprotegerin in Acute Heart Failure. Canadian Journal of Cardiology 31:10, pages 1266-1271.
Crossref
Crossref
M Puato, M Rattazzi, M Zanon, E Benetti, E Faggin, P Palatini & P Pauletto. (2014) Predictors of vascular remodelling in hypertensive subjects with well-controlled blood pressure levels. Journal of Human Hypertension 29:9, pages 561-565.
Crossref
Crossref
M. Kosacka, P. Piesiak, I. Porebska & R. Jankowska. (2015) Correlations between osteoprotegerin serum levels and body composition parameters in patients with sleep apnea syndrome and the possible influence on cardiovascular risk. Revista Portuguesa de Pneumologia (English Edition) 21:5, pages 239-244.
Crossref
Crossref
A. Gaudio, F. Muratore, V. Fiore, R. Rapisarda, S. S. Signorelli & C. E. Fiore. (2015) Decreased bone cortical density at the forearm in subjects with subclinical peripheral arterial disease. Osteoporosis International 26:6, pages 1747-1753.
Crossref
Crossref
Cora McGreevy, Miriam Barry, Colin Davenport, Brendan Byrne, Caroline Donaghy, Geraldine Collier, William Tormey, Diarmuid Smith, Kathleen Bennett & David Williams. (2015) The effect of vitamin D supplementation on arterial stiffness in an elderly community–based population. Journal of the American Society of Hypertension 9:3, pages 176-183.
Crossref
Crossref
J. Paccou, R. Mentaverri, C. Renard, S. Liabeuf, P. Fardellone, Z. A. Massy, M. Brazier & S. Kamel. (2014) The Relationships Between Serum Sclerostin, Bone Mineral Density, and Vascular Calcification in Rheumatoid Arthritis. The Journal of Clinical Endocrinology & Metabolism 99:12, pages 4740-4748.
Crossref
Crossref
Katherine Samaras, Margaret J. Morris, Reginald V. Lord & Mary M. Kavurma. (2014) The effect of bariatric surgery on serum TRAIL and osteoprotegerin levels in obesity complicated by glucose disorders. e-SPEN Journal 9:6, pages e210-e214.
Crossref
Crossref
Federico Biscetti, Carlo Filippo Porreca, Flavio Bertucci, Giuseppe Straface, Angelo Santoliquido, Paolo Tondi, Flavia Angelini, Dario Pitocco, Luca Santoro, Antonio Gasbarrini, Raffaele Landolfi & Andrea Flex. (2014) TNFRSF11B gene polymorphisms increased risk of peripheral arterial occlusive disease and critical limb ischemia in patients with type 2 diabetes. Acta Diabetologica 51:6, pages 1025-1032.
Crossref
Crossref
Adriana Albu, Cosmina I. Bondor, Alexandra M. Crăciun & Daniela Fodor. (2014) Circulating osteoprotegerin and asymptomatic carotid atherosclerosis in postmenopausal non diabetic women. Advances in Medical Sciences 59:2, pages 293-298.
Crossref
Crossref
Katarzyna Klejna, Beata Naumnik, Ewa Koc-Żórawska & Michał Myśliwiec. (2012) Effect of Unfractionated and Low-Molecular-Weight Heparin on OPG, sRANKL, and von Willebrand Factor Concentrations During Hemodialysis. Clinical and Applied Thrombosis/Hemostasis 20:4, pages 433-441.
Crossref
Crossref
M Puato, R Ramonda, A Doria, M Rattazzi, E Faggin, G Balbi, M Zanon, M Zanardo, C Tirrito, M Lorenzin, V Modesti, M Plebani, M Zaninotto, L Punzi & P Pauletto. (2013) Impact of hypertension on vascular remodeling in patients with psoriatic arthritis. Journal of Human Hypertension 28:2, pages 105-110.
Crossref
Crossref
Elizabeth J Samelson, Paul D Miller, Claus Christiansen, Nadia S Daizadeh, Luanda Grazette, Mary S Anthony, Ogo Egbuna, Andrea Wang, Suresh R Siddhanti, Angela M Cheung, Nathalie Franchimont & Douglas P Kiel. (2014) RANKL Inhibition With Denosumab Does Not Influence 3-Year Progression of Aortic Calcification or Incidence of Adverse Cardiovascular Events in Postmenopausal Women With Osteoporosis and High Cardiovascular Risk. Journal of Bone and Mineral Research 29:2, pages 450-457.
Crossref
Crossref
Vasuri Francesco. (2014) Arterial calcification: Finger-pointing at resident and circulating stem cells. World Journal of Stem Cells 6:5, pages 540.
Crossref
Crossref
Alessandra D’Abramo, Maria Antonella Zingaropoli, Alessandra Oliva, Claudia D’Agostino, Samir Al Moghazi, Giulia De Luca, Marco Iannetta, Claudio Maria Mastroianni & Vincenzo Vullo. (2014) Immune Activation, Immunosenescence, and Osteoprotegerin as Markers of Endothelial Dysfunction in Subclinical HIV-Associated Atherosclerosis. Mediators of Inflammation 2014, pages 1-8.
Crossref
Crossref
Alessandra D’Abramo, Claudia D’Agostino, Alessandra Oliva, Marco Iannetta, Gabriella D’Ettorre, Francesco Vullo, Massimo Mancone, Maria Rosa Ciardi, Claudio Maria Mastroianni & Vincenzo Vullo. (2013) Early Atherosclerosis in HIV Infected Subjects on Suppressive Antiretroviral Treatment: Role of Osteoprotegerin. ISRN AIDS 2013, pages 1-6.
Crossref
Crossref
B Naumnik, K Klejna, E Koc-Żórawska & M Myśliwiec. (2013) Age and gender predict OPG level and OPG/sRANKL ratio in maintenance hemodialysis patients. Advances in Medical Sciences 58:2, pages 382-387.
Crossref
Crossref
Mette Bjerre. (2013) Osteoprotegerin (OPG) as a biomarker for diabetic cardiovascular complications. SpringerPlus 2:1.
Crossref
Crossref
A. Galeone, G. Brunetti, C. Rotunno, A. Oranger, S. Colucci, L. de Luca Tupputi Schinosa, A. Zallone, M. Grano & D. Paparella. (2013) Activation of the receptor activator of the nuclear factor- B ligand pathway during coronary bypass surgery: comparison between on- and off-pump coronary artery bypass surgery procedures. European Journal of Cardio-Thoracic Surgery 44:2, pages e141-e147.
Crossref
Crossref
Robert W. van Esch, Maurice M. Kool & Saskia van As. (2013) NSAIDs can have adverse effects on bone healing. Medical Hypotheses 81:2, pages 343-346.
Crossref
Crossref
Jinkwon Kim, Tae-Jin Song, Seung-Hee Yang, Ok-Hee Lee, Hyo Suk Nam, Young Dae Kim, Eun Hee Kim, Hye Sun Lee, Chung Mo Nam & Ji Hoe Heo. (2013) Plasma osteoprotegerin levels increase with the severity of cerebral artery atherosclerosis. Clinical Biochemistry 46:12, pages 1036-1040.
Crossref
Crossref
Hailong Cao, Qingguo Li, Mingna Li, Røe OD, Zhong Wu, Qing Zhou, Bin Cao, Baojun Chen, Yijiang Chen & Dongjin Wang. (2013) Osteoprotegerin/RANK/RANKL axis and atrial remodeling in mitral valvular patients with atrial fibrillation. International Journal of Cardiology 166:3, pages 702-708.
Crossref
Crossref
Stefan Kiechl, Jürgen Wittmann, Andrea Giaccari, Michael Knoflach, Peter Willeit, Aline Bozec, Alexander R Moschen, Giovanna Muscogiuri, Gian Pio Sorice, Trayana Kireva, Monika Summerer, Stefan Wirtz, Julia Luther, Dirk Mielenz, Ulrike Billmeier, Georg Egger, Agnes Mayr, Friedrich Oberhollenzer, Florian Kronenberg, Michael Orthofer, Josef M Penninger, James B Meigs, Enzo Bonora, Herbert Tilg, Johann Willeit & Georg Schett. (2013) Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus. Nature Medicine 19:3, pages 358-363.
Crossref
Crossref
Gang Jee Ko. (2013) A biomarker, osteoprotegerin, in patients undergoing hemodialysis. The Korean Journal of Internal Medicine 28:6, pages 654.
Crossref
Crossref
Hagen Staude, Susann Jeske, Karin Schmitz, Gert Warncke & Dagmar-Christiane Fischer. (2013) Cardiovascular Risk and Mineral Bone Disorder in Patients with Chronic Kidney Disease. Kidney and Blood Pressure Research 37:1, pages 68-83.
Crossref
Crossref
Antonella Galeone, Domenico Paparella, Silvia Colucci, Maria Grano & Giacomina Brunetti. (2013)
The Role of TNF-
α
and TNF Superfamily Members in the Pathogenesis of Calcific Aortic Valvular Disease
. The Scientific World Journal 2013, pages 1-10.
Crossref
Crossref
David M. LeistnerFlorian H. SeegerAriane FischerTino RöxeJens KlotscheKazuma IekushiTimon SeegerBirgit AssmusJörg HonoldMahir KarakasKlaus BadenhoopStefan FrantzStefanie DimmelerAndreas M. Zeiher. (2012) Elevated Levels of the Mediator of Catabolic Bone Remodeling RANKL in the Bone Marrow Environment Link Chronic Heart Failure with Osteoporosis. Circulation: Heart Failure 5:6, pages 769-777.
Crossref
Crossref
Kis Djamiatun, Andre J. A. M. van der Ven, Philip G. de Groot, Sultana M. H. Faradz, D. Hapsari, Wil M. V. Dolmans, Silvie Sebastian, Rob Fijnheer & Quirijn de Mast. (2012) Severe Dengue Is Associated with Consumption of von Willebrand Factor and Its Cleaving Enzyme ADAMTS-13. PLoS Neglected Tropical Diseases 6:5, pages e1628.
Crossref
Crossref
T. Ueland, P. Aukrust, C. P. Dahl, T. Husebye, O. G. Solberg, T. Tønnessen, S. Aakhus & L. Gullestad. (2011) Osteoprotegerin levels predict mortality in patients with symptomatic aortic stenosis. Journal of Internal Medicine 270:5, pages 452-460.
Crossref
Crossref
Qingmiao Yang, Shuzheng Lu, Yundai Chen, Xiantao Song, Zening Jin, Fei Yuan, Hong Li, Yujie Zhou, Fang Chen & Yong Huo. (2011) Plasma Osteoprotegerin Levels and Long‐Term Prognosis in Patients With Intermediate Coronary Artery Lesions. Clinical Cardiology 34:7, pages 447-453.
Crossref
Crossref
Thor UelandChristen P. DahlJohn KjekshusJohannes HultheMichael BöhmFrançois MachAssen GoudevMagnus LindbergJohn WikstrandPål AukrustLars Gullestad. (2011) Osteoprotegerin Predicts Progression of Chronic Heart Failure: Results From CORONA. Circulation: Heart Failure 4:2, pages 145-152.
Crossref
Crossref
G. Cianciolo, G. La Manna, G. Donati, A. Dormi, M. L. Cappuccilli, V. Cuna, C. Legnani, G. Palareti, L. Coli & S. Stefoni. (2010) Effects of unfractioned heparin and low-molecular-weight heparin on osteoprotegerin and RANKL plasma levels in haemodialysis patients. Nephrology Dialysis Transplantation 26:2, pages 646-652.
Crossref
Crossref
Z. Maghbooli, A. Hossein-Nezhad, M. Shirzad & H. Behzadi. (2011) The Role of Osteoprotegrin/Nuclear Factor kB Ligand in Coronary Collateral Development. European Journal of Inflammation 9:1, pages 57-64.
Crossref
Crossref
Stefan Kiechl, Philipp Werner, Michael Knoflach & Johann Willeit. 2012. Ultrasound and Carotid Bifurcation Atherosclerosis. Ultrasound and Carotid Bifurcation Atherosclerosis
487
509
.
Francesco ChiappelliFrancesco Chiappelli. 2011. Osteoimmunopathology. Osteoimmunopathology
39
67
.
Wolfgang LiebPhilimon GonaMartin G. LarsonJoseph M. MassaroIzabella LipinskaJohn F. KeaneyJrJrJian RongDiane CoreyUdo HoffmannCaroline S. FoxRamachandran S. VasanEmelia J. BenjaminChristopher J. O'DonnellSekar Kathiresan. (2010) Biomarkers of the Osteoprotegerin Pathway. Arteriosclerosis, Thrombosis, and Vascular Biology 30:9, pages 1849-1854.
Crossref
Crossref
M. Zagura, M. Serg, P. Kampus, M. Zilmer, K. Zilmer, J. Eha, E. Unt, J. Lieberg & J. Kals. (2010) Association of Osteoprotegerin With Aortic Stiffness in Patients With Symptomatic Peripheral Artery Disease and in Healthy Subjects. American Journal of Hypertension 23:6, pages 586-591.
Crossref
Crossref
Mathias Voigt, Dagmar‐Christiane Fischer, Max Rimpau, Wolfgang Schareck & Dieter Haffner. (2010) Fibroblast growth factor (FGF)‐23 and fetuin‐A in calcified carotid atheroma. Histopathology 56:6, pages 775-788.
Crossref
Crossref
Elena Martin-Bautista, Manuel Muñoz-Torres, Juristo Fonolla, Miguel Quesada, Antonio Poyatos & Eduardo Lopez-Huertas. (2010) Improvement of bone formation biomarkers after 1-year consumption with milk fortified with eicosapentaenoic acid, docosahexaenoic acid, oleic acid, and selected vitamins. Nutrition Research 30:5, pages 320-326.
Crossref
Crossref
Shripad Nagesh Pal & Jonathan Golledge. (2010) Osteo-Progenitors in Vascular Calcification. Journal of Atherosclerosis and Thrombosis 18:7, pages 551-559.
Crossref
Crossref
Joanna B. Tyrovola, Despoina Perrea, Dimitrios J. Halazonetis, Ismene Dontas, Ioannis S. Vlachos & Margarita Makou. (2010) Relation of soluble RANKL and osteoprotegerin levels in blood and gingival crevicular fluid to the degree of root resorption after orthodontic tooth movement. Journal of Oral Science 52:2, pages 299-311.
Crossref
Crossref
Nikolaos P.E. Kadoglou, Nikolaos Sailer, Anestis Moumtzouoglou, Alkistis Kapelouzou, Thomas Gerasimidis & Christos D. Liapis. (2010) Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization. Journal of Vascular Surgery 51:1, pages 114-121.
Crossref
Crossref
Katarzyna Klejna, Beata Naumnik, Katarzyna Gasowska & Michał Myśliwiec. (2009) OPG/RANK/RANKL signaling system and its significance in nephrology.. Folia Histochemica et Cytobiologica 47:2.
Crossref
Crossref
M. Morena, A.-M. Dupuy, I. Jaussent, H. Vernhet, G. Gahide, K. Klouche, A.-S. Bargnoux, C. Delcourt, B. Canaud & J.-P. Cristol. (2009) A cut-off value of plasma osteoprotegerin level may predict the presence of coronary artery calcifications in chronic kidney disease patients. Nephrology Dialysis Transplantation 24:11, pages 3389-3397.
Crossref
Crossref
Christian Luckhaus, Bijan Mahabadi, Brigitte Grass-Kapanke, Michaela Jänner, Holger Willenberg, Marcus Jäger, Tillmann Supprian & Karin Fehsel. (2009) Blood biomarkers of osteoporosis in mild cognitive impairment and Alzheimer’s disease. Journal of Neural Transmission 116:7, pages 905-911.
Crossref
Crossref
Anne G. SembThor UelandPål AukrustNicholas J. WarehamRobert LubenLars GullestadJohn J.P. KasteleinKay-Tee KhawS. Matthijs Boekholdt. (2009) Osteoprotegerin and Soluble Receptor Activator of Nuclear Factor-κB Ligand and Risk for Coronary Events. Arteriosclerosis, Thrombosis, and Vascular Biology 29:6, pages 975-980.
Crossref
Crossref
Ann Van Campenhout & Jonathan Golledge. (2009) Osteoprotegerin, vascular calcification and atherosclerosis. Atherosclerosis 204:2, pages 321-329.
Crossref
Crossref
Izabela Podgorski. (2009) Future of anticathepsin K drugs: dual therapy for skeletal disease and atherosclerosis?. Future Medicinal Chemistry 1:1, pages 21-34.
Crossref
Crossref
Sarath Lekamwasam, Thilak Weerarathna, Mahinda Rodrigo, Wasantha Kodikara Arachchi & Duminda Munidasa. (2009) Osteoporosis and Cardiovascular Risk Among Premenopausal Women in Sri Lanka. Journal of Clinical Densitometry 12:2, pages 245-250.
Crossref
Crossref
A. Wasilewska, A.A. Rybi-Szuminska & W. Zoch-Zwierz. (2009) Serum Osteoprotegrin (OPG) and Receptor Activator of Nuclear Factor κΒ (RANKL) in Healthy Children and Adolescents. Journal of Pediatric Endocrinology and Metabolism 22:12, pages 1099-1104.
Crossref
Crossref
Diane E. WallisSue PenckoferGlen W. Sizemore. (2008) The “Sunshine Deficit” and Cardiovascular Disease. Circulation 118:14, pages 1476-1485.
Crossref
Crossref
David M. Brass, Ivana V. Yang, Marcus P. Kennedy, Gregory S. Whitehead, Holly Rutledge, Lauranell H. Burch & David A. Schwartz. (2008) Fibroproliferation in LPS-induced airway remodeling and bleomycin-induced fibrosis share common patterns of gene expression. Immunogenetics 60:7, pages 353-369.
Crossref
Crossref
Robert D. Nerenz, Melissa L. Martowicz & J. Wesley Pike. (2008) An Enhancer 20 Kilobases Upstream of the Human Receptor Activator of Nuclear Factor-κB Ligand Gene Mediates Dominant Activation by 1,25-Dihydroxyvitamin D3. Molecular Endocrinology 22:5, pages 1044-1056.
Crossref
Crossref
Giovanni Passeri, Rosanna Vescovini, Paolo Sansoni, Carlo Galli, Claudio Franceschi & Mario Passeri. (2008) Calcium metabolism and vitamin D in the extreme longevity. Experimental Gerontology 43:2, pages 79-87.
Crossref
Crossref
Allan Lawrie, Elizabeth Waterman, Mark Southwood, David Evans, Jay Suntharalingam, Sheila Francis, David Crossman, Peter Croucher, Nicholas Morrell & Christopher Newman. (2008) Evidence of a Role for Osteoprotegerin in the Pathogenesis of Pulmonary Arterial Hypertension. The American Journal of Pathology 172:1, pages 256-264.
Crossref
Crossref
G.E.J. Langenbach, T. van Wessel, P. Brugman, J.A.M. Korfage & T.M.G.J. van Eijden. (2008) Is Fiber-Type Composition Related to Daily Jaw Muscle Activity during Postnatal Development?. Cells Tissues Organs 187:4, pages 307-315.
Crossref
Crossref
Stefan KiechlGeorg SchettJudith SchwaigerKlaus SeppiPaula EderGeorg EggerPeter SanterAgnes MayrQingbo XuJohann Willeit. (2007) Soluble Receptor Activator of Nuclear Factor-κB Ligand and Risk for Cardiovascular Disease. Circulation 116:4, pages 385-391.
Crossref
Crossref
Fabrizio Montecucco, Sabine Steffens & François Mach. (2007) The Immune Response Is Involved in Atherosclerotic Plaque Calcification: Could the RANKL/RANK/OPG System Be a Marker of Plaque Instability?. Clinical and Developmental Immunology 2007, pages 1-8.
Crossref
Crossref